Healthcare of Ontario Pension Plan Trust Fund Trims Stake in Xylem Inc. (NYSE:XYL)

Healthcare of Ontario Pension Plan Trust Fund cut its stake in Xylem Inc. (NYSE:XYL - Free Report) by 32.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,000 shares of the industrial products company's stock after selling 7,784 shares during the period. Healthcare of Ontario Pension Plan Trust Fund's holdings in Xylem were worth $2,160,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. Blueshift Asset Management LLC purchased a new position in shares of Xylem in the 3rd quarter valued at approximately $365,000. Glenmede Trust Co. NA grew its stake in shares of Xylem by 3.4% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,399 shares of the industrial products company's stock valued at $2,484,000 after purchasing an additional 605 shares during the period. BNP Paribas Financial Markets grew its position in Xylem by 16.5% during the third quarter. BNP Paribas Financial Markets now owns 547,435 shares of the industrial products company's stock valued at $73,920,000 after buying an additional 77,639 shares during the period. J. Stern & Co. LLP raised its holdings in Xylem by 4.9% in the 3rd quarter. J. Stern & Co. LLP now owns 304,326 shares of the industrial products company's stock worth $41,093,000 after purchasing an additional 14,342 shares during the period. Finally, Lazard Freres Gestion S.A.S. lifted its position in shares of Xylem by 8.8% during the 3rd quarter. Lazard Freres Gestion S.A.S. now owns 6,310 shares of the industrial products company's stock valued at $852,000 after buying an additional 510 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Up 0.2 %

Shares of XYL stock traded up $0.26 during trading hours on Monday, reaching $127.01. 1,418,259 shares of the company's stock were exchanged, compared to its average volume of 1,233,280. The stock's 50 day moving average is $129.37 and its 200-day moving average is $133.65. Xylem Inc. has a fifty-two week low of $104.95 and a fifty-two week high of $146.08. The company has a market cap of $30.86 billion, a price-to-earnings ratio of 36.87, a P/E/G ratio of 2.33 and a beta of 1.05. The company has a current ratio of 1.96, a quick ratio of 1.42 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The business had revenue of $2.10 billion during the quarter, compared to analysts' expectations of $2.17 billion. During the same quarter in the previous year, the firm posted $0.99 EPS. The company's revenue for the quarter was up .2% on a year-over-year basis. Analysts predict that Xylem Inc. will post 4.23 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 24th. Investors of record on Tuesday, November 26th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Tuesday, November 26th. Xylem's dividend payout ratio is presently 42.11%.

Wall Street Analysts Forecast Growth

XYL has been the topic of several research analyst reports. Robert W. Baird lowered their target price on shares of Xylem from $175.00 to $154.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Royal Bank of Canada decreased their price target on shares of Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. UBS Group assumed coverage on shares of Xylem in a report on Tuesday, August 13th. They issued a "buy" rating and a $165.00 target price on the stock. Finally, TD Cowen dropped their price target on Xylem from $138.00 to $125.00 and set a "hold" rating for the company in a research report on Wednesday, November 6th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $149.64.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.